Persistent T cell anergy in human type 1 diabetes

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6933-6940

  Dosch, H Michael ^a   Cheung, Roy K ^a   Karges, Wolfram ^a,b   Pietropaolo, Massimo ^c   Becker, Dorothy J ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ULM   (Germany)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHILD; CLONAL ANERGY; HUMAN; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CLONAL ANERGY; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INFANT; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RISK FACTORS; T-LYMPHOCYTES; THYMIDINE; TIME FACTORS;

EID: 0032759622     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Karges, W., J. Honen, B. H. Robinson, and H.-M. Dosch. 1915. Self and non-self antigen in diabetic autoimmunity: molecules and mechanisms. Mol. Aspects Med. 16:79.
2. Mein, C. A., L. Esposito, M. G. Dunn, G. C. Johnson, A. E. Timms, J. V. Goy, A. N. Smith, L. Sebag-Montefiore, M. E. Merriman, A. J. Wilson, L. E. Pritchard, F. Cucca, A. H. Barnett, S. C. Bain, and J. A. Todd. 1998. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 19:297.
3. Becker, K. G., R. M. Simon, J. E. Bailey-Wilson, B. Freidlin, W. E. Biddison, H. F. McFarland, and J. M. Trent. 1998 Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95:9979.
4. Bingley, P. J., M. R. Christie, E. Bonifacio, R. Bonfanti, M. Shattock, M. T. Fonte, G. E. Bottazzo, and E. A. Gale. 1994. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304.
5. Verge, C. F., R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, R. A. Jackson, H. P. Chase, and G. S. Eisenbarth. 1996. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926.
6. Karjalainen, J., P. Vahasalo, M. Knip, E. Tuomilehto-Wolf, E. Virtala, and H. K. †kerblom. 1996. Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high-and low-risk siblings of diabetic children. The Childhood Diabetes in Finland (DiMe) Study Group. Eur. J. Clin. Invest. 26:640.
7. Roep, B. O. 1996. T cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes 45:1147.
8. Durinovic, B. I., A. Steinle, A. G. Ziegler, and D. J. Schendel. 1994. HLA-DQ-restricted, islet-specific T-cell clones of a type 1 diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43:1318.
9. Endl, J., H. Otto, G. Jung, B. Dreisbusch, F. Donie, P. Stahl, R. Elbracht, G. Schmitz, E. Meinl, M. Hummel, A. G. Ziegler, R. Wank, and D. J. Schendel. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99:2405.
10. Lohmann, T., R. D. Leslie, M. Hawa, M. Geysen, S. Rodda, and M. Londei. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607.
11. Kaufman, D. L., M. G. Erlander, M. Clare-Salzler, M. A. Atkinson, N. K. Maclaren, and A. J. Tobin. 1992. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89:283.
12. Honeyman, M. C., N. Stone, H. de Aizpurua, M. J. Rowley, and L. C. Harrison. 1997. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. J. Autoimmun. 10:165.
13. Honeyman, M. C., D. S. Cram, and L. C. Harrison. 1993. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin dependent diabetes. J. Exp. Med. 177:535.
14. Durinovic, B. I., M. Hummel, and A. G. Ziegler. 1996. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795.
15. Ellis, T. M., D. A. Schatz, E. W. Ottendorfer, M. S. Lan, C. Wasserfall, P. J. Salisbury, J. X. She, A. L. Notkins, N. K. Maclaren, and M. A. Atkinson. 1998. The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566.
16. Rudy, G., N. Stone, L. C. Harrison, P. G. Colman, P. McNair, V. Brusic, M. B. French, M. C. Honeyman, B. Tait, and A. M. Lew. 1995. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1:625.
17. Schloot, N. C., S. Willemen, G. Duinkerken, R. R. de Vries, and B. O. Roep. 1998. Cloned T cells from a recent onset IDDM patient reactive with insulin β-chain. J. Autoimmun. 11:169.
18. Schloot, N. C., B. O. Roep, D. Wegmann, L. Yu, H. P. Chase, T. Wang, and G. S. Eisenbarth. 1997. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564.
19. Roep, B. O., G. Duinkerken, G. M. Schreuder, H. Kolb, R. R. de Vries, and S. Martin. 1996. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1285.
20. Miyazaki, I., R. K. Cheung, R. Gaedigk, M. F. Hui, J. Van der Meulen, R. V. Rajotte, and H.-M. Dosch. 1995. T cell activation and anergy to islet cell antigen in type 1 diabetes. J. Immunol. 154:1461.
21. Karges, W., R. Gaedigk, M. F. Hui, R. K. Cheung, and H.-M. Dosch. 1997. Molecular cloning of murine ICA69: diabetes-prone mice recognize the human autoimmune-epitope, Tep69, conserved in splice variants from both species. Biochim. Biophys. Acta 1360:97.
22. Brooks-Worrell, B. M., G. A. Starkebaum, C. Greenbaum, and J. P. Palmer. 1996. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol. 157:5668.
23. Arden, S. D., B. O. Roep, P. I. Neophytou, E. F. Usac, G. Duinkerken, R. R. de Vries, and J. C. Hutton. 1996. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97:551.
24. Dosch, H.-M., R. K. Cheung, J. C. Gorga, M. Trucco, and D. J. Becker. 1997. Abnormal T cell autoreactivity in IDDM. Diabetes 46 (Suppl 1):58A.
25. Dosch, H.-M., R. K. Cheung, and D. J. Becker. 1996. 15th Immunol Diabetes Workshop, p. 76.
26. Lipton, R. B., M. Kocova, R. E. LaPorte, J. S. Dorman, T. J. Orchard, W. J. Riley, A. L. Drash, D. J. Becker, and M. Trucco. 1992. Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am. J. Epidemiol. 136:503.
27. Lipton, R. B., J. Atchison, J. S. Dorman, R. J. Duquesnoy, K. Eckenrode, T. J. Orchard, R. E. LaPorte, W. J. Riley, L. H. Kuller, A. L. Drash, et al. 1992. Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families. Diabet. Med. 9:224.
28. Kocova, M., M. Blagoivfka, M. Bogoevski, M. Konstantinova, J. Dorman, and M. Trucco. 1995. HLA class II molecular typing in a European slavic population with a low incidence of insulin-dependent diabetes mellitus. Tissue Antigens 45:216.
29. Veijola, R., H. Reijonen, P. Vahasalo, E. Sabbah, P. Kulmala, J. Ilonen, H. K. Akerblom, and M. Knip. 1996. HLA-DQB1-defined genetic susceptibility, β cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. J. Clin. Invest. 98:2489.
30. Miyazaki, I., R. K. Cheung, and H.-M. Dosch. 1993. Viral IL-10 is critical for B cell growth transformation by EBV. J. Exp. Med. 178:439.
31. Abulafia-Lapid, R., D. Elias, I. Raz, Y. Keren-Zur, H. Atlan, and I. R. Cohen. 1999. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 12:121.
32. Kaufman, D. L., M. Clare-Salzer, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
33. Chen, S. L., P. J. Whitely, D. C. Freed, J. B. Rothbard, L. B. Peterson, and L. S. Wicker. 1994. Responses of NOD congenic mice to a GAD-derived peptide. J. Autoimmun. 7:635.
34. Sai, P., A. S. Rivereau, C. Granier, T. Haertle, and L. Martignat. 1996. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin. Exp. Immunol. 105:330.
35. Lohmann, T., R. D. Leslie, and M. Londei. 1996. T cell clones to epitopes of glutamic acid decarhoxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9:385.
36. Quinn, A., and E. E. Sercarz. 1996. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543). J. Autoimmun. 9:365.
37. + Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101:68.
38. Lθvy-Marchal, C., M. P. Bridel, F. Sodoyez-Goffaux, and P. Czernichow. 1991. Superiority of radiobinding assay over ELISA for detection of IAA's in newly diagnosed type 1 diabetic children. Diabetes Care 14:61.
39. Dosch, H.-M., P. Lam, and D. Guerin. 1985. Differential regulation of activation, clonal expansion and antibody secretion in human B cells. J. Immunol. 135:3808.
40. Jaramillo, A., B. M. Gill, and T. L. Delovitch. 1994. Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy?. Life Sci. 55:1163.
41. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by Coxsackievirus: initiation by bystander damage and not mimicry. Nat. Med 4:781.
42. Karges, W., D. Hammond-McKibben, R. Gaedigk, N. Shibuya, R. Cheung, and H.-M. Dosch. 1997. Loss of self-tolerance to 1CA69 in non-obese diabetic mice. Diabetes 46:1548.
43. Congia, M., S. Patel, A. P. Cope, S. De Virgiliis, and G. Sonderstrup. 1998. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc. Natl. Acad. Sci. USA 95:3833.
44. Colucci, F., M. L. Bergman, C. Penha-Goncalves, C. M. Cilio, and D. Holmberg. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. USA 94:8670.
45. Lamhamedi-Cherradi, S. E., J. J. Luan, L. Eloy, G. Fluteau, J. F. Bach, and H. J. Garchon. 1998. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 41:178.
46. Cheung, R. K., J. Karjalainen, J. VanderMeulen, D. Singal, and H.-M. Dosch. 1994. T cells of children with insulin dependent diabetes are sensitized to bovine serum albumin. Scand. J. Immunol. 40:623.
47. Dosch, H.-M., J. C. Gorga, R. K. Cheung, J. Gay, and D. J. Becker. 1997. 16th Int. Diabetes Fed. Congr., p. 273.
48. Greenbaum, C. J., J. P. Palmer, B. Kuglin, and H, Kolb. 1992. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J. Clin. Endocrinol. Metab. 74:1040.
49. Tompkins, S. M., J. C. Moore, and P. E. Jensen. 1996. An insulin peptide that binds an alternative site in class II major histocompatibilily complex. J. Exp. Med. 183:857.
50. Pearson, C. I., W. van Ewijk, and H. O. McDevitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185:583.
51. Zuckerman, L. A., L. Pullen, and J. Miller. 1998. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160:3259.
52. Bergerot, I., G. Arreaza, M. Cameron, H. Chou, and T. L. Delovitch. 1997. Role of T-cell anergy and suppression in susceptibility to IDDM. Res. Immunol. 148: 348.
53. Xiao, B. G., and H. Link. 1997. Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases. Clin. Immunol. Immunopathol. 85:119.
54. Whitacre, C. C., I. E. Gienapp, A. Meyer, K. L. Cox, and N. Javed. 1996. Treatment of autoimmune disease by oral tolerance to autoantigens. Clin. Immunol. Immunopathol. 80(3Pt2):S31.
55. Tyden, G., F. P. Reinholt, G. Sundkvist, and J. Bolinder. 1996. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. [Published erratum appears in 1996 N. Engl. J. Med. 335:1778.]. N. Engl. J. Med. 335:860.
56. Esmatjes, E., C. Rodriguez-Villar, M. J. Ricart, R. Casamitjana, J. Martorell, L. Sabater, E. Astudillo, and L. Fernandez-Cruz. 1998. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 66:128.
57. Stegall, M. D., K. J. Lafferty, I. Kam, and R. G. Gill. 1996. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61:1272.
58. Keymeulen, B., Z. Ling, F. K. Gorus, G. Delvaux, L. Bouwens, A. Grupping, C. Hendrieckx, M. Pipeleers-Marichal, C. Van Schravendijk, K. Salmela, and D. G. Pipeleers. 1998. Implantation of standardized β-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452.
59. Jaeger, C., B. I. Hering, E. Hatziagelaki, K. Federlin, and R. G. Bretzel. 1999. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. J. Mol. Med. 77:45.
60. Marrack, P., I. Kappler, and T. Mitchell. 1999. Type 1 interferons keep activated T cells alive. J. Exp. Med. 189:521.
61. Dosch, H.-M., R. K. Cheung, M. Pietropaolo, and D. J. Becker. 1998. Do proinsulin-& IA-2 specific T cells mark progression of diabetic autoimmunity? Diabetes 47(Suppl. 1):A208.